LATEST TRIALS

  • Solide Tumores
    A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158)
  • Solide Tumores
    MetAction: Actionable Target Identification for Palliative Systemic Therapy
  • Hematological Malignancies
    Dendritic cell-based active immunotherapy of patients with acute myeloid leukemia using autologous cells transfected with RNA encoding two different leukemia-associated antigens

NORDIC COOPERATION

Norway Norway Sweden Finland Aarhus Herlev Copenhagen